Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 12:51 PM ET

Date/Time Source News Release
06/02/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
05/14/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
05/08/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert Speaker at 6th Annual Cytokine-Based Drug Development Summit
03/25/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit
03/20/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
03/18/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
03/13/2025 07:30 AM EDT GlobeNewswire Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
03/12/2025 04:15 PM EDT GlobeNewswire Registration Is Now Open For Tribe Public's Webinar Event "Keys To The Kingdom: Unlocking The Power Of Your Immune System" Featuring Indaptus Therapeutics' CEO On Monday, March 17, 2025
02/25/2025 08:00 AM EST GlobeNewswire Indaptus Therapeutics' Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
02/05/2025 08:00 AM EST GlobeNewswire Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
Page

Additional News

As of June 12, 2025 • 12:51 PM ET

Date/Time Source News Release
05/14/2025 09:36 AM EDT SeekingAlpha Indaptus Therapeutics GAAP EPS of -$0.32 misses by $0.14
05/14/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 14th, 2025
05/14/2025 05:30 AM EDT US Earnings Reports Expected earnings - Indaptus Therapeutics Inc.
05/13/2025 06:48 PM EDT KlickAnalytics INDP - Historical Price Movements Surrounding Earnings
05/13/2025 06:43 PM EDT KlickAnalytics INDP - Historical Earnings Price Analysis
03/13/2025 09:34 AM EDT SeekingAlpha Indaptus Therapeutics GAAP EPS of -$1.61
03/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, March 12th, 2025
03/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Indaptus Therapeutics Inc.
01/13/2025 08:07 AM EST SeekingAlpha Indaptus Therapeutics looks to raise $2.25M in private placement
12/23/2024 05:16 PM EST SeekingAlpha Indaptus Therapeutics files to sell 1.94M shares of common stock
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.